Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

T Magnes; T Melchardt; C Hufnagl; L Weiss; C Mittermair; D Neureiter; E Klieser; G Rinnerthaler; S Roesch; A Gaggl; R Greil; A Egle

doi:10.1038/s41397-019-0073-5

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

Pharmacogenomics J. 2020 Apr;20(2):350. doi: 10.1038/s41397-019-0073-5.

Authors

T Magnes^{1

2

3}, T Melchardt^{1

2

3}, C Hufnagl^{1

2

3}, L Weiss^{1

2

3}, C Mittermair^{1

2

3}, D Neureiter⁴, E Klieser⁴, G Rinnerthaler^{1

2

3}, S Roesch⁵, A Gaggl⁶, R Greil^{1

2

3}, A Egle^{7

8

9}

Affiliations

¹ Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University, Salzburg, Austria.
² Salzburg Cancer Research Institute (SCRI), Salzburg, Austria.
³ Cancer Cluster Salzburg (CCS), Salzburg, Austria.
⁴ Institute of Pathology, Paracelsus Medical University, Salzburg, Austria.
⁵ Department of Otorhinolaryngology, Head and Neck Surgery, Paracelsus Medical University Salzburg, Salzburg, Austria.
⁶ Department of Oral and Maxillofacial Surgery, Paracelsus Medical University Salzburg, Salzburg, Austria.
⁷ Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University, Salzburg, Austria. a.egle@salk.at.
⁸ Salzburg Cancer Research Institute (SCRI), Salzburg, Austria. a.egle@salk.at.
⁹ Cancer Cluster Salzburg (CCS), Salzburg, Austria. a.egle@salk.at.

Abstract

In the abstract and in other parts of the manuscript the authors wrote that the mutation rs396991 causes a valine (V) to phenylalanine (F) substitution at position 157. However, the correct codon number is 158. These errors have not been fixed in the original Article.

Publication types

Published Erratum